지원사업
학술연구/단체지원/교육 등 연구자 활동을 지속하도록 DBpia가 지원하고 있어요.
커뮤니티
연구자들이 자신의 연구와 전문성을 널리 알리고, 새로운 협력의 기회를 만들 수 있는 네트워킹 공간이에요.
이용수
등록된 정보가 없습니다.
논문 유사도에 따라 DBpia 가 추천하는 논문입니다. 함께 보면 좋을 연관 논문을 확인해보세요!
The Role of Neoadjuvant Treatment in Resectable Pancreatic Cancer
대한외과학회 학술대회 초록집
2019 .10
Great Debates: Which is the Best? Resectable pancreatic cancer: Neoadjuvant treatment first
대한임상종양학회 학술대회지
2019 .02
Validation of anatomical and biological definition of borderline resectable cancer according to the 2017 international consensus for survival in patients with resectable and borderline resectable pancreatic ductal adenocarcinoma undergoing upfront surgery
대한임상종양학회 학술대회지
2022 .02
Pancreatectomy following neoadjuvant treatment can improve oncologic outcome in high metabolic active resectable pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2022 .01
Neoadjuvant Treatment Versus Upfront Surgery in Resectable Pancreatic Cancer : Clinical Significance of Portal Vein and Superior Mesenteric Vein Contact and Associated Prognostic Factors
대한외과학회 학술대회 초록집
2021 .11
Surgical strategy for borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
Clinical significance of defining borderline resectable pancreatic cancer
한국간담췌외과학회 학술대회지
2017 .03
Current Definition of Borderline Resectable Pancreatic Cancer and Its Limitation
한국간담췌외과학회 학술대회지
2017 .03
Comments on - Neoadjuvant Chemo-radiation with IMRT in Resectable and Borderline Resectable Pancreatic Cancer
Asian Pacific journal of cancer prevention : APJCP
2015 .01
Does Current Staging System Applicable for Borderline Resectable or Locally Advanced Pancreatic Cancer after Neoadjuvant Chemotherapy?
대한외과학회 학술대회 초록집
2022 .05
The change of clinical stage after neoadjuvant chemotherapy in prediction of prognosis for borderline resectable and locally advanced pancreatic cancer
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Advances in neoadjuvant therapy for resectable pancreatic cancer over the past two decades
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .05
Comparison between neoadjuvant chemotherapy and upfront surgery for patients with resectable and synchronous colorectal cancer hepatic metastases
대한임상종양학회 학술대회지
2019 .02
Corrigendum to: Is Neoadjuvant Therapy Needed in Patients with Resectable Pancreatic Cancer?
Gut and Liver
2023 .03
The comparison of short-term postoperative outcomes between upfront surgery and surgery following neoadjuvant treatment in pancreatic ductal adenocarcinoma
Annals of Hepato-Biliary-Pancreatic Surgery
2021 .12
Clinical benefit of neoadjuvant treatment for borderline resectable PDAC based on RCT
한국간담췌외과학회 학술대회지
2017 .03
Updates of Chemotherapy and Radiotherapy for Pancreatic Cancer
대한췌담도학회지
2020 .01
Role of neoadjuvant treatment for resectable pancreatic ductal adenocarcinoma
한국간담췌외과학회 학술대회지
2017 .03
Validation of anatomical and biological definition of borderline resectable pancreatic cancer according to the 2017 international consensus for survival in patients with resectable and borderline rese
Annals of Hepato-Biliary-Pancreatic Surgery
2022 .12
0